‘Pharma bro’ Martin Shkreli ousted from another drug company

December 21, 2015 3:46 PM

40 0

Martin Shkreli, who became America's favorite Wall Street scoundrel after he recently raised the price of a drug 4,000 percent, has been terminated from another drug company.

On Monday, the publicly traded KaloBios Pharmaceuticals announced that Shkreli was out as chief executive and had resigned from the company's board. It was a short tenure: Shkreli took the helm of KaloBios last month, after buying a majority share in the company.

Also read: Activist Carl Icahn gains control of board in proxy fight at SandRidge Energy

Read more

To category page